To investigate the clinical effect of femoral reconstruction nail in the treatment of femoral neck fractures.

A retrospective analysis was performed on 45 patients with femoral neck fractures in our hospital from January 2018 to Decemberr 2021.There were 30 patients in the CCS group and 15 patients in the femoral reconstruction nail group, with range 18 to 75 years.The main evaluation indicators for both groups of patients include surgical time, bleeding volume, VAS score at 2 days after surgery, early postoperative complications, and time to start partial weight-bearing after surgery, Harris score of the hip joint, fracture reduction, healing status, and degree of femoral neck shortening.

45patients were followed up for 9 to 18 months, mean (13.0±3.1) months. There were 27 males and 18 females, with range 18 to 75. Both groups showed the average operation time was [(64±18.2) vs (82.7±16.2) min, P<0.05], the median bleeding volume was [17.50 (13.75, 30.00) vs 35.00(30.00, 50.00)ml, P<0.001], the median VAS score at 2 days after surgery was [2.00(1.00, 2.00) vs 2.00(1.00, 2.00), P=0.227], the median postoperative partial weight-bearing time was [8.00(6.00, 10.00) vs 2.00(2.00, 3.00) weeks, P<0.001], the median hip joint Harrisscore was [84.00(71.75, 91.00) vs 94.00(88.00, 98.00), P<0.05], the median fracture healing time was [9.00(7.00, 10.00) vs 8.00(7.00, 8.00) months, P=0.075], the median femoral neck shortening length was [4.00(2.00, 7.00) vs 1.00(0.00, 2.00)mm, P<0.001]. Among them, a patient in the CCS group did not heal during the follow-up period, a patient had screw penetration, and a patient did not heal with femoral head necrosis. A patient in the femoral reconstruction nail group did not heal with femoral head necrosis.

The fixation of femoral neck fractures with femoral reconstruction nails has significant clinical advantages, such as early weight bearing, mild shortening of the femoral neck, and good hip joint function.In addition, femoral reconstruction nails are a mature technology that has a long clinical application time and is easy to promote.